![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Biol Chem, Vol. 275, Issue 19, 14255-14259, May 12, 2000
From Tularik Inc., South San Francisco, California 94080
Interleukin-4 (IL-4) is a cytokine that plays a
crucial role in the pathophysiology of asthma and allergic diseases.
IL-4-induced gene expression is largely mediated through the activation
of the latent transcription factor STAT6. We identified a STAT6 mutant (STAT6VT)) that is activated independently of IL-4 stimulation. STAT6VT
carries two amino acid changes in the SH2 domain that affect the
overall structure and stability of the monomeric and dimeric protein.
When overexpressed in mammalian cells, STAT6VT undergoes tyrosine
phosphorylation, binds DNA, and activates transcription in the absence
of IL-4 stimulation. Using the Jak1- and Jak3-deficient fibroblast line
U4A, we demonstrate that phosphorylation is mediated by an
IL-4-independent tyrosine kinase that is not able to activate the
wild-type STAT6 protein. These results suggest that small changes in
STAT6 could result in hyperactivation of the protein and constitutive
expression of STAT6-dependent genes. Such a mutation, if
found in vivo, could cause genetic predisposition for
atopic diseases.
A Gain-of-function Mutation in STAT6*
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Tularik Inc., Two
Corporate Dr., South San Francisco, CA 94080. Tel.: 650-825-7482; Fax:
650-825-7400; E-mail: uli@tularik.com.
This article has been cited by other articles:
![]() |
S. Sehra, H. A. Bruns, A.-N. N. Ahyi, E. T. Nguyen, N. W. Schmidt, E. G. Michels, G.-U. von Bulow, and M. H. Kaplan IL-4 Is a Critical Determinant in the Generation of Allergic Inflammation Initiated by a Constitutively Active Stat6 J. Immunol., March 1, 2008; 180(5): 3551 - 3559. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Kaplan, S. Sehra, H.-C. Chang, J. T. O'Malley, A. N. Mathur, and H. A. Bruns Constitutively active STAT6 predisposes toward a lymphoproliferative disorder Blood, December 15, 2007; 110(13): 4367 - 4369. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Cortes, M. Perez-G, M. D. Rivas, and J. Zamorano Kaempferol Inhibits IL-4-Induced STAT6 Activation by Specifically Targeting JAK3 J. Immunol., September 15, 2007; 179(6): 3881 - 3887. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takatori, H. Nakajima, S.-i. Kagami, K. Hirose, A. Suto, K. Suzuki, M. Kubo, A. Yoshimura, Y. Saito, and I. Iwamoto Stat5a Inhibits IL-12-Induced Th1 Cell Differentiation through the Induction of Suppressor of Cytokine Signaling 3 Expression J. Immunol., April 1, 2005; 174(7): 4105 - 4112. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. U. Lee and A. Rao Molecular analysis of a locus control region in the T helper 2 cytokine gene cluster: A target for STAT6 but not GATA3 PNAS, November 9, 2004; 101(45): 16010 - 16015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Travagli, M. Letourneur, J. Bertoglio, and J. Pierre STAT6 and Ets-1 Form a Stable Complex That Modulates Socs-1 Expression by Interleukin-4 in Keratinocytes J. Biol. Chem., August 20, 2004; 279(34): 35183 - 35192. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Gillespie, R. R. DeMartino, J. Zhu, H. J. Chong, C. Ramirez, C. P. Shelburne, L. A. Bouton, D. P. Bailey, A. Gharse, P. Mirmonsef, et al. IL-10 Inhibits Fc{epsilon}RI Expression in Mouse Mast Cells J. Immunol., March 1, 2004; 172(5): 3181 - 3188. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Lin, C.-M. Chou, Y.-L. Hsu, J.-C. Lien, Y.-M. Wang, S.-T. Chen, S.-C. Tsai, P.-W. Hsiao, and C.-J. Huang Characterization of Two Mosquito STATs, AaSTAT and CtSTAT: DIFFERENTIAL REGULATION OF TYROSINE PHOSPHORYLATION AND DNA BINDING ACTIVITY BY LIPOPOLYSACCHARIDE TREATMENT AND BY JAPANESE ENCEPHALITIS VIRUS INFECTION J. Biol. Chem., January 30, 2004; 279(5): 3308 - 3317. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, H. Nakajima, K. Ikeda, Y. Maezawa, A. Suto, H. Takatori, Y. Saito, and I. Iwamoto IL-4-Stat6 Signaling Induces Tristetraprolin Expression and Inhibits TNF-{alpha} Production in Mast Cells J. Exp. Med., December 1, 2003; 198(11): 1717 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Bruns, U. Schindler, and M. H. Kaplan Expression of a Constitutively Active Stat6 In Vivo Alters Lymphocyte Homeostasis with Distinct Effects in T and B Cells J. Immunol., April 1, 2003; 170(7): 3478 - 3487. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhu, L. Guo, C. J. Watson, J. Hu-Li, and W. E. Paul Stat6 Is Necessary and Sufficient for IL-4's Role in Th2 Differentiation and Cell Expansion J. Immunol., June 15, 2001; 166(12): 7276 - 7281. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |